Company / Free Cash Flow
TREACE MEDICAL CONCEPTS, INC. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$46.0M
FY2025
5-year range
-$46.0M / -$5.6M
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 3 consecutive years, from -$6M in FY2022 to -$46M in FY2025.
Based on SEC 10-K filings.
-$46M in FY2025.
Declined from -$20M to -$46M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s free cash flow has declined for 3 consecutive years.
- In FY2025, free cash flow decreased 1.2% year-over-year.
- Peak free cash flow was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$46.0M | -1.2% |
| FY2024 | -$45.5M | -128.6% |
| FY2023 | -$19.9M | -257.7% |
| FY2022 | -$5.6M | +37.4% |
| FY2021 | -$8.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026